Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 1
2008 2
2010 1
2012 2
2013 1
2016 2
2017 1
2019 3
2020 2
2021 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
Did you mean iprasidone/PD (276,347 results)?
Integrative Systematic Review on Pharmacological, Psychotherapeutic, and Neurostimulatory Treatment Options in Treatment-Resistant Anxiety Disorders.
Schiele MA, Fagan HA, Baldwin DS, Domschke K. Schiele MA, et al. Psychother Psychosom. 2026;95(3):214-247. doi: 10.1159/000547926. Epub 2025 Sep 14. Psychother Psychosom. 2026. PMID: 40946318 Free article.
According to RCTs, selective serotonin reuptake inhibitors (SSRIs) or clomipramine are effective in TR-PD after failure to respond to cognitive behavioral therapy (CBT). In pharmacological TR-SAD, switching from one SSRI to another or to venlafaxine was found helpful in op …
According to RCTs, selective serotonin reuptake inhibitors (SSRIs) or clomipramine are effective in TR-PD after failure to respond to …
A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.
Younce JR, Davis AA, Black KJ. Younce JR, et al. J Parkinsons Dis. 2019;9(1):63-71. doi: 10.3233/JPD-181448. J Parkinsons Dis. 2019. PMID: 30475775 Free PMC article.
The atypical antipsychotic ziprasidone has been considered inappropriate for use in patients with Parkinson's disease (PD), as most atypical antipsychotics worsen parkinsonism. ...Our case series did not support efficacy of ziprasidone; it was generally safe …
The atypical antipsychotic ziprasidone has been considered inappropriate for use in patients with Parkinson's disease (PD), as …
Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Zahodne LB, Fernandez HH. Zahodne LB, et al. Drugs Aging. 2008;25(8):665-82. doi: 10.2165/00002512-200825080-00004. Drugs Aging. 2008. PMID: 18665659 Free PMC article. Review.
The use of anti-PD medications (particularly dopamine receptor agonists) has been the most widely identified risk factor for PD psychosis. ...Preliminary reports have also shown a potential relationship between deep brain stimulation surgery and PD psychosis. …
The use of anti-PD medications (particularly dopamine receptor agonists) has been the most widely identified risk factor for PD …
Management of hallucinations and psychosis in Parkinson's disease.
Eng ML, Welty TE. Eng ML, et al. Am J Geriatr Pharmacother. 2010 Aug;8(4):316-30. doi: 10.1016/j.amjopharm.2010.08.004. Am J Geriatr Pharmacother. 2010. PMID: 20869621 Review.
Several reviews, guidelines, and consensus statements have sought to establish standards for treating these symptoms of PD. In 2006, the American Academy of Neurology (AAN) published a practice guideline (based on articles published up to 2004) for management of depression …
Several reviews, guidelines, and consensus statements have sought to establish standards for treating these symptoms of PD. In 2006, …
Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease.
Lertxundi U, Peral J, Mora O, Domingo-Echaburu S, Martínez-Bengoechea MJ, García-Moncó JC. Lertxundi U, et al. Am J Health Syst Pharm. 2008 Mar 1;65(5):414-9. doi: 10.2146/ajhp060624. Am J Health Syst Pharm. 2008. PMID: 18281732 Review.
PURPOSE: A literature evaluation of antidopaminergic therapies in patients with Parkinson's disease (PD) who have developed psychosis, nausea, vomiting, and hiccups was conducted. SUMMARY: Complications associated with the use of antiparkinsonian drugs make PD manag …
PURPOSE: A literature evaluation of antidopaminergic therapies in patients with Parkinson's disease (PD) who have developed psychosis …
Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review.
Masdrakis VG, Baldwin DS. Masdrakis VG, et al. Ther Adv Psychopharmacol. 2021 Mar 21;11:20451253211002320. doi: 10.1177/20451253211002320. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 33815761 Free PMC article. Review.
BACKGROUND: As the remission rate of panic disorder (PD) achieved with conventional pharmacotherapy ranges between 20% and 50%, alternative psychopharmacological strategies are needed. ...Additionally, bipolar patients receiving valproate or quetiapine-XR (but not risperid …
BACKGROUND: As the remission rate of panic disorder (PD) achieved with conventional pharmacotherapy ranges between 20% and 50%, alter …
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.
Lauterbach EC. Lauterbach EC. Am J Neurodegener Dis. 2016 Mar 1;5(1):29-51. eCollection 2016. Am J Neurodegener Dis. 2016. PMID: 27073741 Free PMC article. Review.
Psychiatric disorders, prevalent in AD and PD, are often treated with psychiatric drugs (psychotropics), raising the question of whether psychotropics might therapeutically affect microglial activation, MCI, and PD. ...Clinical data limited to pramipexole do not as …
Psychiatric disorders, prevalent in AD and PD, are often treated with psychiatric drugs (psychotropics), raising the question of whet …
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.
Perna G, Alessandra A, Raffaele B, Elisa M, Giuseppina D, Paolo C, Maria N, Daniela C. Perna G, et al. Int J Mol Sci. 2016 Apr 13;17(4):551. doi: 10.3390/ijms17040551. Int J Mol Sci. 2016. PMID: 27089322 Free PMC article.
Among 210 studies, five were included (two involving patients with a principal diagnosis of PD and three involving patients with bipolar disorder with comorbid PD or generalized anxiety disorder). ...Except for ziprasidone, SGAs were well tolerated in these s …
Among 210 studies, five were included (two involving patients with a principal diagnosis of PD and three involving patients with bipo …
Pharmacological interventions for treatment-resistant depression in adults.
Davies P, Ijaz S, Williams CJ, Kessler D, Lewis G, Wiles N. Davies P, et al. Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD010557. doi: 10.1002/14651858.CD010557.pub2. Cochrane Database Syst Rev. 2019. PMID: 31846068 Free PMC article.
Eight studies augmented current antidepressant treatment with a non-antidepressant (either an anxiolytic (buspirone) or an antipsychotic (cariprazine; olanzapine; quetiapine (3 studies); or ziprasidone (2 studies)). We judged most studies to be at a low or unclear risk of …
Eight studies augmented current antidepressant treatment with a non-antidepressant (either an anxiolytic (buspirone) or an antipsychotic (ca …
Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
Pintor L, Valldeoriola F, Baillés E, Martí MJ, Muñiz A, Tolosa E. Pintor L, et al. Clin Neuropharmacol. 2012 Mar-Apr;35(2):61-6. doi: 10.1097/WNF.0b013e31824d5115. Clin Neuropharmacol. 2012. PMID: 22388466 Clinical Trial.
RESULTS: Fourteen patients completed the study, 8 patients on clozapine and 6 patients on ziprasidone. The final mean dosage for clozapine was 32.14 mg/d and that for ziprasidone was 35 mg/d. ...CONCLUSIONS: Ziprasidone seems to be at least as effective as cl …
RESULTS: Fourteen patients completed the study, 8 patients on clozapine and 6 patients on ziprasidone. The final mean dosage for cloz …
20 results